Clinical Trial Update: Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating brachytherapy with or without triptorelin hormone therapy for recurrent prostate cancer was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Triptorelin (triptorelin)

Snippet

Sponsor: Ipsen | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-02-23